The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
More surprises lying ahead. The endocannabinoids keep us guessing
Open accessAbstract
The objective of this review is to point out some important facts that we don't know about endogenous cannabinoids - lipid-derived signaling molecules that activate CB1 cannabinoid receptors and play key roles in motivation, emotion and energy balance. The first endocannabinoid substance to be discovered, anandamide, was isolated from brain tissue in 1992. Research has shown that this molecule is a bona fide brain neurotransmitter involved in the regulation of stress responses and pain, but the molecular mechanisms that govern its formation and the neural pathways in which it is employed are still unknown. There is a general consensus that enzyme-mediated cleavage, catalyzed by fatty acid amide hydrolase (FAAH), terminates the biological actions of anandamide, but there are many reasons to believe that other as-yet-unidentified proteins are also involved in this process. We have made significant headway in understanding the second arrived in the endocannabinoid family, 2-arachidonoyl-sn-glycerol (2-AG), which was discovered three years after anandamide. Researchers have established some of the key molecular players involved in 2-AG formation and deactivation, localized them to specific synaptic components, and showed that their assembly into a multi-molecular protein complex (termed the '2-AG signalosome') allows 2-AG to act as a retrograde messenger at excitatory synapses of the brain. Basic questions that remain to be answered pertain to the exact molecular composition of the 2-AG signalosome, its regulation by neural activity and its potential role in the actions of drugs of abuse such as Δ(9)-THC and cocaine. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fatty acid amide hydrolase (FAAH) catalyzes the intracellular hydrolysis of the endocannabinoid anandamide.”
From Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment (2016) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×
“…the molecular characterization of a cell-surface receptor that recognizes marijuana’s main psychoactive constituent, Δ9-tetrahydrocannabinol (Δ9-THC)(Devane et al., 1988; Matsuda et al., 1990), had finally answered the longstanding question of how this compound exerts its unique brand of…”
Opiate Receptor: Demonstration in Nervous Tissue
Pert, C. B., & Snyder, S. H. (1973) · Science · doi:10.1126/science.179.4077.1011 · Cited by 2,389
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585
Self-citationA second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Self-citation
Cited by
Sorted by citations
Djuricic, I. D., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13072421 · Cited by 1,094
Arachidonic acid: Physiological roles and potential health benefits – A review
Tallima, H., & El Ridi, R. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2017.11.004 · Cited by 671
Cannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 440
Endocannabinoid-mediated retrograde modulation of synaptic transmission
Ohno‐Shosaku, T., & Kano, M. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.017 · Cited by 260
Peripheral gating of pain signals by endogenous lipid mediators
Piomelli, D., & Sasso, O. (2014) · Nature Neuroscience · doi:10.1038/nn.3612 · Cited by 240
Self-citationEndocannabinoid signaling mediates oxytocin-driven social reward
Wei, D., Lee, D., Cox, C. D., Karsten, C. A., Peñagarikano, O., Geschwind, D. H., Gall, C. M., & Piomelli, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509795112 · Cited by 218
Self-citationGajda, A. M., & Storch, J. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.10.001 · Cited by 205
Endocannabinoids, Related Compounds and Their Metabolic Routes
Fezza, F., Bari, M., Florio, R., Talamonti, E., Feole, M., & Maccarrone, M. (2014) · Molecules · doi:10.3390/molecules191117078 · Cited by 187
Ogasawara, D., Deng, H., Viader, A., Baggelaar, M. P., Breman, A. C., den Dulk, H., van den Nieuwendijk, A. M. C. H., Soethoudt, M., van der Wel, T., Zhou, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522364112 · Cited by 158
Lee, S.-H., Ledri, M., Toth, B., Marchionni, I., Henstridge, C. M., Dudok, B., Kenesei, K., Barna, L., Szabo, S. I., Renkecz, T., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4112-14.2015 · Cited by 133
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
Befort, K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00006 · Cited by 139
Control of synaptic function by endocannabinoid-mediated retrograde signaling
Kano, M. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.235 · Cited by 134
Wei, D., Dinh, D., Lee, D., Li, D., Anguren, A., Moreno-Sanz, G., Gall, C. M., & Piomelli, D. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0008 · Cited by 122
Self-citationPolyunsaturated fatty acids and endocannabinoids in health and disease
Freitas, H. R., Isaac, A. R., Malcher‐Lopes, R., Diaz, B. L., Trevenzoli, I. H., & Reis, R. A. D. M. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1347373 · Cited by 118
Role of the endocannabinoid system in drug addiction
Manzanares, J., Cabañero, D., Puente, N., García‐Gutiérrez, M. S., Grandes, P., & Maldonado, R. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.013 · Cited by 118
Endocannabinoid Signaling in the Control of Social Behavior
Don, W., Allsop, S. A., Tye, K. M., & Piomelli, D. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.005 · Cited by 120
Self-citationThe search for novel analgesics: targets and mechanisms
Yaksh, T. L., Woller, S. A., Ramachandran, R., & Sorkin, L. S. (2015) · F1000Prime Reports · doi:10.12703/p7-56 · Cited by 100
Intestinal lipid–derived signals that sense dietary fat
DiPatrizio, N. V., & Piomelli, D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76302 · Cited by 100
Self-citationWang, W., Trieu, B. H., Palmer, L. C., Jia, Y., Pham, D. T., Jung, K., Karsten, C. A., Merrill, C. B., Mackie, K., Gall, C. M., et al. (2016) · eNeuro · doi:10.1523/eneuro.0160-16.2016 · Cited by 87
Self-citationDyall, S. C. (2017) · Lipids · doi:10.1007/s11745-017-4292-8 · Cited by 95
Boileau, I., Mansouri, E., Williams, B., Le Foll, B., Rusjan, P., Mizrahi, R., Tyndale, R. F., Huestis, M. A., Payer, D. E., Wilson, A. A., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.012 · Cited by 82
Laricchiuta, D., & Petrosini, L. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00238 · Cited by 82
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
Davis, M. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918603 · Cited by 81
The Endocannabinoid System as a Therapeutic Target in Glaucoma
Cairns, E. A., Baldridge, W. H., & Kelly, M. E. M. (2016) · Neural Plasticity · doi:10.1155/2016/9364091 · Cited by 76
Monoglyceride lipase: Structure and inhibitors
Scalvini, L., Piomelli, D., & Mor, M. (2015) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.07.011 · Cited by 69
Self-citationZimmermann, T., Bartsch, J., Beer, A., Lomazzo, E., Guggenhuber, S., Lange, M. D., Bîndilă, L., Pape, H., & Lutz, B. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0274-7 · Cited by 68
Mechanisms of endocannabinoid control of synaptic plasticity
Winters, B. L., & Vaughan, C. W. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108736 · Cited by 70
Wilhelmsen, K., Khakpour, S., Tran, A., Sheehan, K., Schumacher, M. A., Xu, F., & Hellman, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.536953 · Cited by 56
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions
Zlebnik, N. E., & Cheer, J. F. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1712-16.2016 · Cited by 58
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats
Lim, J., Igarashi, M., Jung, K., Butini, S., Campiani, G., & Piomelli, D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.284 · Cited by 53
Self-citationClassical endocannabinoid‐like compounds and their regulation by nutrients
Kleberg, K., Hassing, H. A., & Hansen, H. S. (2014) · BioFactors · doi:10.1002/biof.1158 · Cited by 51
Luca, M. A. D., Valentini, V., Bimpisidis, Z., Cacciapaglia, F., Caboni, P., & Chiara, G. D. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00140 · Cited by 51
Endogenous cannabinoid signaling at inhibitory interneurons
Younts, T. J., & Castillo, P. E. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.12.006 · Cited by 52
Biosynthesis and Fate of Endocannabinoids
Cascio, M. G., & Marini, P. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_2 · Cited by 53
Richey, J. M., & Woolcott, O. O. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0924-x · Cited by 50
Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways
DiPatrizio, N. V., Igarashi, M., Narayanaswami, V., Murray, C. H., Gancayco, J., Russell, A., Jung, K., & Piomelli, D. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00239.2015 · Cited by 48
Self-citationDócs, K., Mészár, Z., Gonda, S., Kiss‐Szikszai, A., Holló, K., Antal, M., & Hegyi, Z. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00039 · Cited by 49
Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics
Knežević, N. N., Yekkirala, A. S., & Yaksh, T. L. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002442 · Cited by 43
Boileau, I., Rusjan, P., Williams, B., Mansouri, E., Mizrahi, R., Luca, V. D., Johnson, D. S., Wilson, A. A., Houle, S., Kish, S. J., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.133 · Cited by 41
Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases
Baggelaar, M. P., van Esbroeck, A. C. M., van Rooden, E. J., Florea, B. I., Overkleeft, H. S., Marsicano, G., Chaouloff, F., & van der Stelt, M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01052 · Cited by 42
Don, W., Lee, D., Li, D., Daglian, J. M., Jung, K., & Piomelli, D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4222-0 · Cited by 44
Self-citationLee, H.-L., Jung, K.-M., Fotio, Y., Squire, E., Palese, F., Lin, L., Torrens, A., Ahmed, F., Mabou Tagne, A., Ramirez, J., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.04.017 · Cited by 38
Self-citationBatista, L. A., Gobira, P. H., Viana, T. G., de Aguiar, D. C., & Moreira, F. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000073 · Cited by 38
Murillo‐Rodríguez, E., Marzo, V. D., Machado, S. E. D. C., Rocha, N., Veras, A. B., Neto, G. D. A. M., Budde, H., Arias-Carrión, Ó., & Arankowsky‐Sandoval, G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00152 · Cited by 38
Allosteric Modulators Targeting Cannabinoid cb1 and cb2 Receptors: Implications for Drug Discovery
Gado, F., Meini, S., Bertini, S., Digiacomo, M., Macchia, M., & Manera, C. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0005 · Cited by 42
Cannabis Use and the Endocannabinoid System: A Clinical Perspective
Haney, M. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.21111138 · Cited by 35
Chamlagain, M., Hu, J., Sionov, R. V., & Steinberg, D. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1333274 · Cited by 37
RETRACTED: Understanding the possible role of endocannabinoid system in obesity
Behl, T., Chadha, S., Sachdeva, M., Sehgal, A., Kumar, A., Dhruv, Venkatachalam, T., Hafeez, A., Aleya, L., Arora, S., et al. (2020) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2020.106520 · Cited by 33
RetractedKeenan, C. M., Storr, M., Thakur, G. A., Wood, J. T., Wager‐Miller, J., Straiker, A. J., Eno, M. R., Nikas, S. P., Bashashati, M., Hu, H., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13069 · Cited by 32
Hu, H. Y., Kruijssen, D. L. H., Frias, C. P., Rózsa, B. J., Hoogenraad, C. C., & Wierenga, C. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.078 · Cited by 31
Sun, Y., & Yang, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-40694-4 · Cited by 31
Chauvet, C., Nicolas, C., Thiriet, N., Lardeux, V., Duranti, A., & Solinas, M. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu025 · Cited by 30
Blanco, E., Galeano, P., Palomino, A., Pavón, F. J., Rivera, P., Serrano, A., Alén, F., Rubio, L., Vargas, A., Castilla‐Ortega, E., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.040 · Cited by 29
The Role of the Cannabinoid System in Opioid Analgesia and Tolerance
Özdemir, E. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200313120835 · Cited by 28
Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse
Muhl, D., Kathmann, M., Hoyer, C., Kranaster, L., Hellmich, M., Gerth, C. W., Faulhaber, J., Schlicker, E., & Leweke, F. M. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-0984-2 · Cited by 27
Bioactive Lipids in MSCs Biology: State of the Art and Role in Inflammation
Casati, S., Giannasi, C., Niada, S., Bergamaschi, R. F., Orioli, M., & Brini, A. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031481 · Cited by 25
Pietropaolo, S., & Marsicano, G. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.031 · Cited by 23
Palmisano, M., Gargano, A., Olabiyi, B. F., Lutz, B., & Bilkei‐Gorzó, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010026 · Cited by 26
mGlu5 function in the nucleus accumbens core during the incubation of methamphetamine craving
Murray, C. H., Christian, D., Milovanovic, M., Loweth, J. A., Hwang, E.-K., Caccamise, A. J., Funke, J. R., & Wolf, M. E. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108452 · Cited by 23
Synaptic effects of cannabinoids
Benarroch, E. E. (2014) · Neurology · doi:10.1212/wnl.0000000000001013 · Cited by 25
Feliszek, M., Bindila, L., Lutz, B., Zimmer, A., Bilkei-Gorzo, A., & Schlicker, E. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1226-6 · Cited by 22
Axonal CB1 Receptors Mediate Inhibitory Bouton Formation via cAMP Increase and PKA
Liang, J., Kruijssen, D. L. H., Verschuuren, A. C. J., Voesenek, B. J. B., Benavides, F. F. W., González, M. S., Ruiter, M., & Wierenga, C. J. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0851-21.2021 · Cited by 22
Cannabinoids in Health and Disease
Meccariello, R., & Chianese, R. (2016) · InTech eBooks · doi:10.5772/61595 · Cited by 22
Identification of a Widespread Palmitoylethanolamide Contamination in Standard Laboratory Glassware
Angelini, R., Argueta, D. A., Piomelli, D., & DiPatrizio, N. V. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0019 · Cited by 21
Self-citationScarpelli, R., Sasso, O., & Piomelli, D. (2015) · ChemMedChem · doi:10.1002/cmdc.201500395 · Cited by 21
Self-citationPerescis, M. F. J., Flipsen, N. A. R., van Luijtelaar, G., & van Rijn, C. M. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106722 · Cited by 19
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons
Heinbockel, T., & Wang, Z.-J. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13010005 · Cited by 19
Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases
Bosch‐Bouju, C., & Layé, S. (2016) · InTech eBooks · doi:10.5772/62498 · Cited by 22
Diverse role of endocannabinoid system in mammalian male reproduction
Sayed, T. S., Balasinor, N., & Nishi, K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120035 · Cited by 18
Δ9-THC reduces reward-related brain activity in healthy adults
Murray, C. H., Glazer, J. E., Lee, R., Nusslock, R., & de Wit, H. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06164-y · Cited by 16
Briand‐Mésange, F., Pons, V., Allart, S., Masquelier, J., Chicanne, G., Beton, N., Payrastre, B., Muccioli, G. G., Ausseil, J., Davignon, J., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015278 · Cited by 15
Kroll, S. L., Hulka, L. M., Kexel, A.-K., Vonmoos, M., Preller, K. H., Treyer, V., Ametamey, S. M., Baumgartner, M. R., Boost, C., Pahlisch, F., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02628-7 · Cited by 19
Feeding regulation by oleoylethanolamide synthesized from dietary oleic acid
Igarashi, M., Iwasa, K., & Yoshikawa, K. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102228 · Cited by 14
Murray, C. H., Gaulden, A. D., Kawa, A. B., Milovanovic, M., Caccamise, A. J., Funke, J. R., Patel, S., & Wolf, M. E. (2021) · eNeuro · doi:10.1523/eneuro.0220-21.2021 · Cited by 13
Almeida‐Santos, A. F., Moreira, F. A., Guimarães, F. S., & de Aguiar, D. C. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117704986 · Cited by 12
Jayanthi, S., Peesapati, R., McCoy, M. T., Ladenheim, B., & Cadet, J. L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02656-8 · Cited by 11
Downstream effects of endocannabinoid on blood cells: implications for health and disease
Gasperi, V., Evangelista, D., Savini, I., Principe, D. D., Avigliano, L., Maccarrone, M., & Catani, M. V. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1924-0 · Cited by 11
The endocannabinoid system in the visual process
Pasquaré, S. J., Chamorro-Aguirre, E., & Gaveglio, V. L. (2022) · Journal of Photochemistry and Photobiology · doi:10.1016/j.jpap.2022.100159 · Cited by 9
Murray, C. H., Haney, M., Foltin, R. W., Manubay, J. M., Bedi, G., & Cooper, Z. D. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109757 · Cited by 9
Contributions of site- and sex-specific LTPs to everyday memory
Gall, C. M., Le, A. A., & LYNCH, G. S. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2023.0223 · Cited by 10
Cannabinoids for Pain Management
Mosley, C. I., Gaynor, J. S., Cital, S. N., & Brassard, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-68317-7_5 · Cited by 12
2-Arachidonoylglycerol Attenuates Myocardial Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway
Chen, Z., Zheng, L., & Chen, G. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07307-7 · Cited by 9
Endocannabinoid Signaling in Neural Circuits of the Olfactory and Limbic System
Heinbockel, T., Wang, Z., Brown, E. A., & Austin, P. T. (2016) · InTech eBooks · doi:10.5772/63214 · Cited by 9
Matias, M. E., Radulski, D. R., da Silva, T. R., Raymundi, A. M., Stern, C. A. J., & Zampronio, A. R. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110745 · Cited by 9
Veeraraghavan, P., & Nistri, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.045 · Cited by 7
Blair, R. E., Deshpande, L. S., & DeLorenzo, R. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417041-4.00006-0 · Cited by 7
Cannabinoid-Based Drugs: Potential Applications in Addiction and Other Mental Disorders
Don, W., & Piomelli, D. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20150009 · Cited by 7
Self-citationGamma-Aminobutyric Acid (GABA) and the Endocannabinoids: Understanding the Risks and Opportunities
JAMES, S. P., & Bondugji, D. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99242 · Cited by 6
Palmisano, M., Ramunno, C. F., Farhat, E., Dvir‐Ginzberg, M., Lutz, B., de Almodóvar, C. R., & Bilkei‐Gorzó, A. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111954 · Cited by 5
Combinatorial approaches for treating neuropsychiatric social impairment
Don, W., Tsheringla, S., McPartland, J. C., & Allsop, S. A. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0051 · Cited by 6
Hu, S., Cheng, G., Chen, G.-C., Zhou, H., Zhang, Q., Zhao, Q., Lian, C.-X., Zhao, Z., Zhang, Q., Han, T., et al. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.105536 · Cited by 4
Bazán, H. A., Bhattacharjee, S., Reid, M. M., Jun, B., Polk, C., Strain, M., Pierre, L. S., Desai, N. N., Daly, P. J., Cucinello‐Ragland, J. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61791-z · Cited by 4
Oxygenation of Anandamide by Lipoxygenases
van Zadelhoff, G., & van der Stelt, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3539-0_22 · Cited by 4
Cannabinoids and Endocannabinoids
Jung, K., & Piomelli, D. (2015) · Springer eBooks · doi:10.1007/978-1-4614-6434-1_136-1 · Cited by 4
Self-citationCannabinoids and Endocannabinoids
Jung, K., & Piomelli, D. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3474-4_136 · Cited by 4
Self-citationmGluR5, CB1 and neuroprotection
Carvalho, T. G., Doria, J. G., & Ribeiro, F. M. (2016) · Oncotarget · doi:10.18632/oncotarget.14086 · Cited by 4
Lipids | The Endocannabinoid System
Jung, K., & Piomelli, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21365-4 · Cited by 4
Self-citationNistri, A., Vilotti, S., & Fabbretti, E. (2015) · Journal of Receptor Ligand and Channel Research · doi:10.2147/jrlcr.s50993 · Cited by 3
Veeraraghavan, P., Dekanic, A., & Nistri, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.021 · Cited by 3
Health Perspective of Nutraceutical Fatty Acids; (Omega‐3 and Omega‐6 Fatty Acids)
Desai, S. S., & Mane, V. K. (2020) · Wiley eBooks · doi:10.1002/9781119631729.ch9 · Cited by 3
Metadata
- Authors
- Piomelli, D.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Piomelli, Daniele
- ORCID
- Piomelli, Daniele
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 76
- Pages
- 228-234
- ISSN
- 0028-3908 (ISSN-L)
- PMC
- PMC3855347
- OpenAlex
- W2030135878
- Cited by
- 128
- References
- 89
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 6 · 2023: 7 · 2022: 13 · 2021: 11 · 2020: 9 · 2019: 5 · 2018: 4 · 2017: 13 · 2016: 17 · 2015: 20 · 2014: 17
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute on Drug Abuse (DA012413, R01DA012413, DA-031387, DP1DA031387)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- endocannabinoids, anandamide, fatty acid amide hydrolase, retrograde signaling, CB1 receptor, stress response, pain, drug abuse, delta-9-tetrahydrocannabinol, cocaine
- MeSH terms
- Fatty Acid Amide Hydrolases, Amidohydrolases, Animals, Arachidonic Acids, Humans, Substance-Related Disorders, Receptors, Cannabinoid, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
